I understand it was high risk program. But this was the type of buyout at the time you said to yourself, this would end up as either very dumb or very smart move. It turned out to be dumb for MEDX unfortunately. That is all I am saying. I was MEDX shareholder at that time, didn't do badly.
I have to do a little plug I normally don't do: MITI is MEDX type of company in my opinion.
Market Data 
Markets 
AI
